A recent study found that only 15% of cancer survivors discussed trials with their healthcare providers, with ...

Objective Phase II trials suggest glucagon-like peptide-1 receptor (GLP1) agonists resolve metabolic dysfunction-associated steatohepatitis but do not affect fibrosis regression. We aimed to determine ...

Digital health interventions (DHIs) show promise for the treatment of mental health disorders. However, existing ...

Here we use cryogenic electron microscopy to determine the structure of TbAQP2 from Trypanosoma brucei, bound to either the substrate glycerol or to the sleeping sickness drugs, pentamidine or ...

Interpreting trial results following use of different intention-to-treat approaches for preventing attrition bias: a meta-epidemiological study protocol ...

CHICAGO — Adults with type 2 diabetes and chronic kidney disease have a lower risk for adverse renal outcomes with semaglutide, regardless of their BMI at drug initiation, researchers ...

Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA’s Clinical Hold on Gene Therapy Trial – Hagens Berman ...

Effectiveness of a transdiagnostic individually tailored Internet-based and mobile-supported intervention for the indicated prevention of depression and anxiety (ICare Prevent) in Dutch college ...

Benefits of Intermittent fasting (IF) on health-related outcomes have been found in a range of randomised controlled trials (RCTs). Our umbrella review aimed to systematically analyze and synthesize ...

Diddy Trial: Chart Cataloguing 71 Potential Freak Offs Reveals Conflict at the Heart of the Case Government Exhibit 1402 was meant to just summarize data about "certain meetings" that may have ...

Introduction Direct-to-family clinical trials efficiently provide data while reducing the participation burden for children and their families. Although these trials can offer significant advantages ...

Knowledge Generated Based on a meta-analysis of 67 trials comprising N = 12,000 US-based participants conducted by 10 sponsors, large declines in trial enrollment, major protocol deviations, dropouts, ...